S. 2157 · 118th Congress (2023–2025)
Protect Drug Innovation Act
This bill repeals several programs and requirements that were enacted under the Inflation Reduction Act of 2022 relating to the prices of prescription drugs, including (1) the Medicare Drug Price Negotiation Program, (2) provisions that require drug manufacturers to issue rebates for certain drugs under Medicare for which prices increase faster than inflation, and (3) provisions that cap annual out-of-pocket spending under the Medicare prescription drug benefit.
Show official title
A bill to repeal prescription drug price control provisions of the Inflation Reduction Act.
Expired in Senate committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to committee
This bill’s path
This is S. 2157’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
Expired
- Sponsor
- Sen. Mike Lee (R-UT)
- Cosponsors
1 cosponsor
1 original · 0 later
- Sen. Marco Rubio (R-FL)· Original · Jun 22, 2023
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Read twice and referred to the Committee on Finance.
Sources
- Congress.gov action
- Senate
Expired
Introduced → Referred to Senate Finance → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in Senate |
Titles (2)
Protect Drug Innovation Act
Display title, Short title · Introduced in Senate
A bill to repeal prescription drug price control provisions of the Inflation Reduction Act.
Official title · Introduced in Senate